The drugmaker claims the executives obtained low-priced diabetes strips intended for mail-order customers and sent them to pharmacies for resale, which allowed them to profit when the pharmacies marked up the price.
The drugmaker claims the practice caused Roche to wrongfully pay $87 million and to lose a similar amount of sales in retail strips.
The lawsuit, filed in U.S. district court in New Jersey, names several defendants, including Jeffrey Smith, former CEO of Alliance Medical Holdings.
In a separate lawsuit in Michigan, Roche alleges that executives at other medical supply companies used a similar scheme.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
